Help accelerate Southern Research's work against COVID-19.
Learn More
BIRMINGHAM, Ala. – April 6, 2015 – Alan Stokes, Ph.D., today joined Southern Research’s drug development division as the director of toxicology and pathology at its Birmingham headquarters. In this […]
BIRMINGHAM, Ala. – March 11, 2015 – Southern Research – developer of seven FDA-approved cancer drugs – will be exhibiting at the Society of Toxicology (SOT) 54th Annual Meeting and […]
BIRMINGHAM, Alabama – December 9, 2014 – Southern Research is broadening its preclinical service offerings in drug development with the addition of Good Laboratory Practices (GLP)-compliant in vitro safety pharmacology […]
BIRMINGHAM, BATON ROUGE, RALEIGH and RESEARCH TRIANGLE PARK – December 8, 2014 – Five biopharmaceutical research organizations with operations in Birmingham, Baton Rouge, Raleigh and Research Triangle Park have formed a […]
BIRMINGHAM, Alabama – December 1, 2014 – Southern Research has been awarded a $24 million, seven-year contract with the Division of AIDS, part of the National Institutes of Health, to […]
BIRMINGHAM, Ala. and SHREVEPORT, La. — Using preclinical molecular imaging, scientists from Southern Research Institute and LSU Health Sciences Center in Shreveport have published data which could lead to better […]
BIRMINGHAM, Ala. — Southern Research today announced that it has signed an agreement with Apath, LLC which will allow Southern Research to conduct laboratory testing, research, and/or screening of potential […]
BIRMINGHAM, Ala. – Southern Research today announced that it has been awarded a contract from the U.S. Dept. of Health and Human Services (HHS) Biomedical Advanced Research and Development Authority […]